European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis

A Wollenberg, C Flohr, D Simon, M J Cork, J P Thyssen, T Bieber, M S de Bruin-Weller, S Weidinger, M Deleuran, A Taieb, C Paul, M Trzeciak, T Werfel, J Seneschal, S Barbarot, U Darsow, A Torrelo, J-F Stalder, Å Svensson, D HijnenC Gelmetti, Z Szalai, U Gieler, L De Raeve, B Kunz, P Spuls, L B von Kobyletzki, R Fölster-Holst, P V Chernyshov, S Christen-Zaech, A Heratizadeh, J Ring, C Vestergaard

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)e241-e242
JournalJEADV : journal of the European Academy of Dermatology and Venereology
Volume34
Issue number6
DOIs
Publication statusPublished - 1 Jun 2020

Keywords

  • Advisory Committees
  • COVID-19
  • Comorbidity
  • Coronavirus Infections/epidemiology
  • Dermatitis, Atopic/drug therapy
  • Europe
  • Female
  • Humans
  • Immunocompromised Host/drug effects
  • Immunosuppressive Agents/therapeutic use
  • Male
  • Pandemics
  • Pneumonia, Viral/epidemiology
  • Practice Guidelines as Topic
  • Risk Assessment
  • Severe Acute Respiratory Syndrome/epidemiology
  • Treatment Outcome

Cite this